Ahmed Bahi on Qatar’s Self-Infusion Program for Hemophilia Patients
Ahmed Bahi, Critical Care Pharmacist Specialist in Trauma Services at Hamad Medical Corporation, shared on LinkedIn:
”Exciting News from Qatar!
I’m thrilled to share the successful establishment of our self-infusion program for hemophilia patients, a collaborative effort between Qatar Foundation Health Group (QFHG) and the Hematology/Oncology team at Hamad Medical Corporation’s National Center for Cancer Care and Research (NCCCR).
This initiative included comprehensive didactic lectures and hands-on live stations, culminating in a knowledge assessment survey to ensure our patients feel empowered and informed.
A heartfelt thank you to everyone involved, especially:
– Dr. Osama Elhomsi
– Dr. Honar Cherif
– Dr. Liam Ferrnough
– Dr.Sheab Fared
– Dr.Amna Jameel
– Dr.Deena Mudawi
Your dedication and expertise made this program a reality, significantly improving the quality of life for hemophilia patients in our community.
Together, we are making strides toward better healthcare and patient empowerment!”
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 09:32Kalyan Roy: Swirling as a Simple Indicator of Platelet Quality
-
Apr 14, 2026, 09:26Kausik Ray: How Physicians and Patients Perceive Risk in Lipid Modification Therapy
-
Apr 14, 2026, 09:14Hossam Qassem: When To Start Anticoagulation After Cerebral Aneurysm Clipping
-
Apr 14, 2026, 09:09Kevin Land: Near Elimination of Vaso-Occlusive Crises in Sickle Cell Disease
-
Apr 14, 2026, 07:58Anton Ilich։ A New Test for Rapid Detection of Fibrinolysis in Postpartum Hemorrhage
-
Apr 13, 2026, 17:41Peter Zdziarski: Glanzmann’s Research Foundation Listed as GT Patient Organization on NORD
-
Apr 13, 2026, 17:39Nathan Connell: Why Prophylaxis in vWD Has Historically Lagged Behind Established Practice in Hemophilia
-
Apr 13, 2026, 17:38Tareq Abadl: A Blood Transfusion Can Cause a Delayed Platelet Crash
-
Apr 13, 2026, 13:33Tetsumei Urano: Join for the ISTH Educational Programs at APSTH 2026 in Japan